LogoLogo
Ctrlk
Digital Twin SafeClinipediaRight to Trial ActAPI DocsWikidFDA
  • ๐Ÿ’ŠThe Decentralized FDA
  • ๐Ÿ“˜Historical Evidence Supporting Decentralized Efficacy Trials
  • โ˜ ๏ธProblems With the Current Model
    • ๐ŸฅซNo Data on Unpatentable Molecules
    • ๐Ÿ’ฐClinical Research is Expensive
    • ๐ŸฅธTrials Often Aren't Representative of Real Patients
    • โ“We Know Next to Nothing
    • โฑ๏ธDeaths Due to US Regulatory "Drug Lag"
    • ๐Ÿ™ˆNegative Results are Never Published
    • ๐ŸŽญConflicts of Interest
    • ๐Ÿ—“๏ธNo Long-Term Outcome Data
    • ๐Ÿ“ƒLack of Incentive to Discover the Full Range of Applications for Off-Patent Treatments
    • ๐Ÿค’People With Rare Disease are Severely Punished
    • ๐Ÿ”ฎPre-Determining Clinical Endpoints Requires Psychic Powers
  • ๐ŸŽฏBenefits of a Decentralized Model
  • ๐Ÿ“–References
Powered by GitBook
On this page
Edit

โ˜ ๏ธProblems With the Current Model

The current system of clinical research is too slow, expensive, and imprecise.

๐ŸฅซNo Data on Unpatentable Molecules๐Ÿ“ƒLack of Incentive to Discover the Full Range of Applications for Off-Patent Treatments๐Ÿ—“๏ธNo Long-Term Outcome Data๐ŸŽญConflicts of Interest๐Ÿ™ˆNegative Results are Never Published๐ŸฅธTrials Often Aren't Representative of Real Patients
PreviousHistorical Evidence Supporting Decentralized Efficacy TrialsNextNo Data on Unpatentable Molecules

Last updated 1 year ago

Was this helpful?

Links

  • API Docs
  • Right to Trial Act

Was this helpful?